Upcoming Earnings Overview Labcorp Holdings Inc. is set to release its latest quarterly earnings on Wednesday, April 29th, with a consensus estimate EPS of 4.09.
Live Analysis Labcorp Holdings Inc. is currently priced at $262.33, showing a decrease of $1.09 (-0.416%) from the previous close. The trading volume is at $118,043, representing an 18.68% increase relative to the average.
Performance Streak The asset has experienced a four-day streak of price decline, with a total absolute change of -$11.09 (-4.05%) since the streak started at $273.42.
Earnings Overview In the latest quarterly earnings report on Monday, February 16th, Labcorp Holdings Inc. reported an EPS of $1.98, with a consensus estimate of 3.95.
Dividends The company offers a forward dividend yield of 1.1%, with a dividend per share of 72 cents MRQ and $2.88 TTM.
Cash Flow Labcorp Holdings Inc. generated a free cash flow of $490.3 million, with net cash decreasing by $65.8 million. Operating cash flow stood at $614.2 million.
Income Statement The company reported a net income of $164.7 million, with a gross profit of $920.6 million. EBITDA was $418.6 million, and operating income reached $382 million.
Ratios Key ratios include a net profit margin of 4.68%, return on equity of 1.91%, and a price-to-earnings ratio of 31.42.
Balance Sheet Labcorp Holdings Inc. maintains cash and cash equivalents of $532.30 million, total assets of $18.39 billion, and total liabilities of $9.76 billion. Total debt stands at $7.21 billion.
This financial snapshot provides insights into Labcorp Holdings Inc.'s current market performance and financial health.
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.